Success Stories: Our Efficient Team Helps an Internal Medicine Resident in Thoracic Oncology from Austria Win NIW Approval in Less Than 5 Months

Client’s Testimonial:

“Having professional support during this process was essential for the success of my case. I highly recommend this firm. I received perfect instructions and timely responses to my questions—the team from NAILG drafted my letters with the information I provided. A series of revisions from my side and their side leveraged the quality of the materials. Finally, having professionals reviewing and organizing the paperwork alleviated the stress and provided a framework that, in my case, helped me balance my daily professional and personal endeavors. Thank you for your hard work and professionalism.”

On March 15^th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for an Internal Medicine Resident in the Field of Thoracic Oncology (Approval Notice).

General Field: Thoracic Oncology

Position at the Time of Case Filing: Internal Medicine Resident

Country of Origin: Austria

State of Residence at the Time of Filing: Connecticut

Approval Notice Date: March 15^th, 2022

Processing Time: 4 months, 13 days

Case Summary:

Our NIW client from Austria had a Ph.D. in malignant diseases and was considered an expert in the field of thoracic oncology due to his years of contribution to the field both academically and professionally. Since the EB2-NIW category of nonimmigrant visa is for those foreign nationals who can prove the worth of their research for the United States, we found that our Austrian client was the perfect candidate for it.

His proposed endeavor was to continue his research on developing state-of-the-art approaches for identifying biomarkers and therapeutic targets involved in drug resistance in order to improve cancer patients’ survival rates. It was evident that his research is of great importance because it improves the therapies available for treating all forms of cancer, and thoracic cancer in particular, which primarily includes lung cancer and malignant pleural mesothelioma. So, our team rummaged through his CVs, transcripts, certificates, and letters of recommendation to find more relevant information such as the follows:

His research has resulted in 13 peer-reviewed journal articles (4 of them first-authored) and 16 peer-reviewed abstracts (5 of them first-authored).
These publications have been cited a total of 102 times according to Google Scholar.
Furthermore, his study has received funding from 4 international organizations, namely the FWF Austrian Science Fund, the Hungarian National Research, Development, and Innovation Office, the Vienna Fund for Innovative Interdisciplinary Cancer Research, and Boehringer Ingelheim.
We also attached 2 letters of recommendation obtained by our client at our request to further bolster his claim to the NIW category.
We also showed that he has pursued research directly related to his proposed endeavor of developing state-of-the-art approaches for identifying biomarkers and therapeutic targets involved in drug resistance for implementation in routine patient care in order to improve cancer patients’ survival rates for 7 years.
On the other hand, in the absence of his research, Americans suffering from cancer will continue to lack the innovative treatments necessary to improve survival rates.

We had been able to thus show that his education, experience, expertise, documented record of success, influence in his field, and future plan have altogether well positioned him to advance the proposed endeavor of developing state-of-the-art approaches for identifying biomarkers and therapeutic targets involved in drug resistance in order to improve cancer patients’ survival rates. These facts helped us to establish that it was beneficial to the United States to waive the requirements of a job offer and labor certification for him. We were hence very glad to hear of his NIW case approval in less than 5 months. We are grateful to our client for his trust in us and for retaining us to file his I-485 petition.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.